The
diabetes medication sitagliptin seems to decrease the severity of reactive
hypoglycemia, a variety of low blood sugar that happens after a meal, a
preliminary survey finds. The outcomes will be introduced Sunday at The
Endocrine Society's 94th Annual Meeting in Houston.
"Further
research studies may verify if it is a possibility to use sitagliptin being a
novel method of treat this condition, for which here currently is not any
health therapy," said command investigator, Francisco Gomez-Perez, MD, of
Instituto Nacional de Ciencias Medicas y Nutricion SZ in Mexico City.
Also
termed as postprandial hypoglycemia, responsive hypoglycemia can take place in
both diabetic and nondiabetic individuals, usually after consuming
carbohydrates, or sugars. Signs and symptoms comprise anxiety, heart palpitations,
tremor (shakiness), sweating, and giddiness, tingling of the fingers,
difficulty concentrating and weakness. Existing treatment that is not always successful
entails keeping off high-sugar foods and eating tiny portions during the day,
Gomez-Perez said.
The
presumed reason behind reactive hypoglycemia serves as a delayed secretion of
the hormone insulin for ingested carbohydrates, he said. Insulin is required
for the right time to manage the rise in blood sugar that typically follows a
meal.
Medical
professionals prescribe sitagliptin (marketed as Januvia) to lower glucose, or
blood sugar, degrees in grown-ups with Diabetes type 2. Gomez-Perez with the
exceptional co-workers hypothesized this medication might decrease the symptoms
of responsive hypoglycemia.
No comments:
Post a Comment